Agilent Technologies, Inc.

A Healthcare Diagnostics & Research

Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024.

Revenue
+8.06%
EPS
+8.47%
Free cash flow
+69.5%
Total debt
+8.81%

Quarter to July 2026, against a year earlier

173.61 1.83 +1.07%
Market cap
$48.4B
P/E
33.8×
Fwd P/E
34.1×
Dividend yield
0.59%
F-score
5/9
Altman Z
5.46
Beneish M
−2.46
Dividend safety
86/100

Agilent Technologies, Inc. 10-Q filed Jun 1, 2026

Fiscal Q2 2026 · Period ended Apr 30, 2026 · Filed · accepted 4:09 PM ET · Document on sec.gov · Filing index

What changed

Part II, Item 1A, Risk Factors, against the 10-Q filed Mar 3, 2026: 2 added · 1 removed · 11 modified; 3 with only figures updated